These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 9559602)
1. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602 [TBL] [Abstract][Full Text] [Related]
2. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. Avontuur JA; Tutein Nolthenius RP; Buijk SL; Kanhai KJ; Bruining HA Chest; 1998 Jun; 113(6):1640-6. PubMed ID: 9631805 [TBL] [Abstract][Full Text] [Related]
3. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock. Avontuur JA; Stam TC; Jongen-Lavrencic M; van Amsterdam JG; Eggermont AM; Bruining HA Intensive Care Med; 1998 Jul; 24(7):673-9. PubMed ID: 9722036 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Kiehl MG; Ostermann H; Meyer J; Kienast J Intensive Care Med; 1997 May; 23(5):561-6. PubMed ID: 9201529 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock. Avontuur JA; Biewenga M; Buijk SL; Kanhai KJ; Bruining HA Shock; 1998 Jun; 9(6):451-4. PubMed ID: 9645498 [TBL] [Abstract][Full Text] [Related]
6. Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Broccard A; Hurni JM; Eckert P; Liaudet L; Schaller MD; Lazor R; Perret C; Feihl F Shock; 2000 Jul; 14(1):35-40. PubMed ID: 10909891 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR; Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555 [TBL] [Abstract][Full Text] [Related]
10. Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock. Weitzberg E; Rudehill A; Modin A; Lundberg JM Crit Care Med; 1995 May; 23(5):909-18. PubMed ID: 7736750 [TBL] [Abstract][Full Text] [Related]
11. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259 [TBL] [Abstract][Full Text] [Related]
12. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J; Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554 [TBL] [Abstract][Full Text] [Related]
13. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Grover R; Zaccardelli D; Colice G; Guntupalli K; Watson D; Vincent JL Crit Care Med; 1999 May; 27(5):913-22. PubMed ID: 10362413 [TBL] [Abstract][Full Text] [Related]
14. Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine. Cohen RI; Shapir Y; Davis A; Loona R; Scharf SM Crit Care Med; 2000 Sep; 28(9):3257-67. PubMed ID: 11008990 [TBL] [Abstract][Full Text] [Related]
15. Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock. Effects of nitric oxide synthase inhibition. Dahm PL; Thörne J; Myhre E; Grins E; Mårtensson L; Blomquist S Acta Anaesthesiol Scand; 1999 Jan; 43(1):56-63. PubMed ID: 9926190 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Booke M; Hinder F; McGuire R; Traber LD; Traber DL Crit Care Med; 1996 May; 24(5):835-44. PubMed ID: 8706462 [TBL] [Abstract][Full Text] [Related]
17. Effects of N omega-nitro-L-arginine methyl ester on the endotoxin-induced disseminated intravascular coagulation in porcine septic shock. Jourdain M; Tournoys A; Leroy X; Mangalaboyi J; Fourrier F; Goudemand J; Gosselin B; Vallet B; Chopin C Crit Care Med; 1997 Mar; 25(3):452-9. PubMed ID: 9118662 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of exhaled nitric oxide production during sepsis does not prevent lung inflammation. Aaron SD; Valenza F; Volgyesi G; Mullen JB; Slutsky AS; Stewart TE Crit Care Med; 1998 Feb; 26(2):309-14. PubMed ID: 9468170 [TBL] [Abstract][Full Text] [Related]
19. Porcine endotoxemic shock is associated with increased expired nitric oxide. Mehta S; Javeshghani D; Datta P; Levy RD; Magder S Crit Care Med; 1999 Feb; 27(2):385-93. PubMed ID: 10075065 [TBL] [Abstract][Full Text] [Related]
20. Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. Avontuur JA; Boomsma F; van den Meiracker AH; de Jong FH; Bruining HA Circulation; 1999 Jan; 99(2):271-5. PubMed ID: 9892594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]